FIPB approves FDI proposals of Lupin, Alkem Laboratories

20 Oct 2015 Evaluate

The Foreign Investment Promotion Board (FIPB), chaired by Economic Affairs Secretary in its meeting considered and approved 14 FDI proposals. FIPB has approved the foreign investment proposals of Lupin and Alkem Laboratories under the automatic route.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally. The company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and Cephalosporin segment.



Lupin Share Price

1601.00 -4.35 (-0.27%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.